Managing malignancies of the eye and surrounding structures demands early detection and highly individualized treatment strategies. The field of ocular oncology and orbital tumors brings together diagnostic imaging, histopathology, and molecular profiling to improve patient outcomes. From retinoblastoma in children to ocular melanomas and lymphoproliferative lesions in adults, these conditions require a multidisciplinary approach involving oncologists, ophthalmologists, and radiologists. Technological advances in orbital imaging and targeted therapy are allowing for more conservative treatment plans, reducing the need for enucleation while preserving vision and aesthetics. Surgical precision in orbital tumor resection continues to improve with intraoperative navigation tools. Moreover, attention is growing around survivorship care, addressing both visual rehabilitation and cosmetic reconstruction. As researchers uncover genetic markers and develop immunotherapeutic options, the prognosis for orbital and intraocular tumors is gradually improving, highlighting the need for continued collaboration across oncology and vision science disciplines.







Title : Lenadogene nolparvovec gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : Stereotactic radiotherapy for wet age-related macular degeneration: year 4 results of a randomised, double-masked, sham-controlled trial
Tim Jackson, King’s College London, United Kingdom